Clarity AI, the creator of an investment impact assessment platform, secured the funding in a round led by potential strategic partner Deutsche Börse.

University of Colorado and Osage University Partners both backed a round that took the immune regulation-focused university spinout's total funding to at least $106m.

Bloomberg Beta and Slack Fund were among the investors that provided $12m for the workplace messaging tool developer.

The plant-based ingredient developer's series D round was co-led by GV and backed by Louis Dreyfus Company and Emart.

Grupo Jacto subsidiary Tridon helped the agricultural data technology provider boost its overall funding to $38m./

Novo, Bristol Myers-Squibb and Merck Group scored exits as the fibrosis and cancer drug developer priced its shares in the middle of the IPO's range.

Sanofi Ventures and Children's Hospital Colorado have returned to back Q32 Bio, an immune regulation-focused university spinout that has now raised at least $106m to date.

Propel Dayton is a three-phase accelerator targeting pre-spinout concepts leveraging University of Dayton's intellectual property.

Kraft Heinz's corporate venturing subsidiary joined counterparts at existing investors Koch and Prologis to bring the logistics automation technology producer’s total funding to $118m.

4100 Group led an extension to the Stanford-StartX Fund-backed healthcare AI technology provider's latest round, which now stands at $30m.